by newsworm | Mar 8, 2025 | Lupin, Pharma
Lupin, a global pharmaceutical company, has launched its anti-clotting drug Rivaroxaban in the US market. The company has received approval from the United States Food and Drug Administration (FDA) to market the medication, which is used to treat conditions such as... by newsworm | Mar 8, 2025 | Pharma
Here is a summary of the content in 400 words: ILUMYA, a novel biologic treatment, has been found effective in treating moderate-to-severe plaque psoriasis affecting the nails in a recent study presented at the 2025 American Academy of Dermatology (AAD) conference.... by newsworm | Mar 7, 2025 | Biocon, Pharma
Biocon Biologics has announced positive results from the Phase 3 clinical trial for its biosimilar, Yesintek, in treatment-naive patients with moderate-to-severe plaque psoriasis. The study met its primary endpoint, demonstrating the efficacy and safety of Yesintek in... by newsworm | Mar 7, 2025 | Pfizer, Pharma
Pfizer has appointed James List, a former executive from Johnson & Johnson, as its new Chief Internal Medicine Officer to enhance the company’s efforts in obesity drug development. List has a strong background in the pharmaceutical industry, with over 20... by newsworm | Mar 7, 2025 | Apollo Hospital, Fortis, Pharma
Dr. Rooma Sinha, Dr. Swapna Misra, and Dr. Uddhavraj Dudhedia are emphasizing the urgency of adopting robotic-assisted surgery to combat the growing incidence of gynaecological disorders in India. The prevalence of conditions like fibroids, ovarian cysts,... by newsworm | Mar 7, 2025 | Fortis, Pharma
Here is a summary of the content in 400 words: Healthcare staffing firms are consolidating under the Fortis Healthcare Solutions brand. According to Staffing Industry Analysts, staffing giants are embracing this move to expand their presence in the industry. Prime... by newsworm | Mar 7, 2025 | Aurobindo Pharma, Pharma
Aurobindo Pharma Limited, a leading pharmaceutical company, has terminated its licence agreement with Hilleman Biosciences Inc. for the pediatric pentavalent vaccine, a product that protects against five serious childhood diseases, namely, diphtheria, tetanus,... by newsworm | Mar 7, 2025 | Cipla, Pharma
The article focuses on Cipla Ltd. (NSE:CIPLA), a Indian pharmaceutical company, and its financial performance, specifically its Return on Equity (ROE). The ROE measures a company’s ability to generate profits from its shareholders’ investment.... by newsworm | Mar 6, 2025 | Pharma
Senores Pharmaceuticals, a company, has announced that it will acquire 14 Abbreviated New Drug Applications (ANDAs) from Dr. Reddy’s Laboratories. The acquisition includes 13 ANDAs that have already received approval from the US Food and Drug Administration... by newsworm | Mar 6, 2025 | Pfizer, Pharma
Havas, a global advertising holding company, has reported “record results” in its first year as a separate entity, but its net revenue growth of 1.5% to €2,736 million is modest. Organic growth was down 0.8%, likely due to a flat Q4, where many of its...